International Journal of Cancer

Article	Citations
	165
Issue Information	143
	118
Issue Information	112
Issue Information	100
Issue Information	93
Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs	92
Erratum	83
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study	83
Issue Information	80
Maternal illnesses during pregnancy and the risk of childhood cancer: A medical‐record based analysis (UKCCS)	72
	71
Issue Information	68
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target	63
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)	63
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer	59
Education level and risk of breast cancer by tumor subtype in the EPIC cohort	58
	58
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities	57
Household air pollution and risk of incident lung cancer in urban China: A prospective cohort study	56
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization	52
Celecoxib promotes the efficacy of STING‐targeted therapy by increasing antitumor CD8+ T‐cell functions via modulating glucose metabolism of CD11b+	52
A comprehensive investigation of histotype‐specific microRNA and their variants in Stage I epithelial ovarian cancers	51
Sequential acquisition of human papillomavirus infection between genital and oral anatomic sites in males	50
Comments on “Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer”	50

Association between fish oil supplementation and cancer risk according to fatty fish consumption: A large prospective population‐based cohort study using UK Biobank	50
Accuracy of different triage strategies for human papillomavirus positivity in an Italian screening population	49
Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry‐based study	49
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study	48
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort	48
Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration d	47
Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk	47
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study	46
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center	45
Mammographic breast density, body mass index and risk of breast cancer in Korean women aged 75 years and older	45
Ovarian cancer survival in sub‐Saharan Africa by human development index and histological subtypes: A population‐based registry study	44
The landscape of genetic aberrations in myxofibrosarcoma	44
Immune‐related conditions and cancer‐specific mortality among older adults with cancer in the United States	43
Improving colon cancer screening in Poland. In search of the Holy Grail	43
Longitudinal associations of plasma metabolites with persistent fatigue among colorectal cancer survivors up to 2 years after treatment	42
Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer	41
Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study	40
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials	40
Pre‐diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study	39
Socioeconomic position and risk of cervical cancer in the Nordic countries: Results from the Nordic Occupational Cancer Study	39
Survival rates and extra‐regional migration patterns of children and adolescents with cancer in Italy: The 30‐year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) wi	39
Association of aflatoxin with gallbladder cancer in a case‐control study nested within a Chinese cohort	39
	38
Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population‐based patient cohort study in southern China	38
tRNA‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression	38
Characterisation of anal intraepithelial neoplasia and anal cancer in HIV‐positive men by immunohistochemical markers p16, Ki‐67, HPV‐E4 and DNA methylation markers	37
Single‐cell RNA‐seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer	37
Changes in cancer incidence rates by stage during the COVID‐19 pandemic in the US	37
International Anal Neoplasia Society's consensus guidelines for anal cancer screening	37
The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV‐associated tumors: A review	37
Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries	37
Issue Information	36
Safe prescribing in cancer patients during the COVID‐19 pandemic and outcomes following restart of cancer care following SARS‐CoV‐2 infection: The COV‐	35
Issue Information	35
Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status	35
Issue Information	35
Issue Information	35
Harnessing normalcy: The potential of healthy tissue for patient outcomes	35
Issue Information	35
Issue Information	35
Genome‐wide exploration of genetic interactions for bladder cancer risk	34
Age‐specific burden of cervical cancer associated with HIV: A global analysis with a focus on sub‐Saharan Africa	34
Audit of laboratory sensitivity of human papillomavirus and cytology testing in a cervical screening program	34
14‐3‐3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer	33
Changes in weight and waist circumference during menopausal transition and postmenopausal breast cancer risk	33
Erratum to “Surveillance of premalignant gastric cardia lesions: A population‐based prospective cohort study in China”	33
Exploration of immunotherapy in advanced pulmonary lymphoepithelioma‐like carcinoma	32
Erratum	32
Uncovering possible silent acquired long QT syndrome using exercise stress testing in long‐term pediatric acute lymphoblastic leukemia survivors	32
Combination of pimitespib (TAS‐116) with sunitinib is an effective therapy for imatinib‐resistant gastrointestinal stromal tumors	32

DNA methylation landscape of tumor‐associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple‐negative breast cancer patients	32
Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR	31
Oral human papillomavirus (HPV) infection and HPV vaccination in an Australian cohort	31
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients	31
Person‐years of life lost and lost earnings from cigarette smoking‐attributable cancer deaths, United States, 2019	30
Eventual success rate and predictors of success for oncology drugs tested in phase I trials	30
Sex differences in cancer incidence and mortality among patients managed at King Hussein Cancer Center	30
Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes	30
Microenvironment and drug resistance in acute myeloid leukemia: Do we know enough?	29
Multiple primary lung cancer: Updates and perspectives	29
Cancer‐related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors	29
Pre‐diagnostic plasma advanced glycation end‐products and soluble receptor for advanced glycation end‐products and mortality in colorectal cancer patients	29
Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation	29
Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk	29
Special issue “The advance of solid tumor research in China”: Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors	29
Interaction of leisure‐time physical activity with body mass index on the risk of obesity‐related cancers: A pooled study	29
Metformin and other anti‐diabetic medication use and breast cancer incidence in the Nurses' Health Studies	28
Incidence of late recurrence and second primary cancers 5–10 years after non‐metastatic colorectal cancer	28
Deposition of onco‐histone H3.3‐G34W leads to DNA repair deficiency and activates cGAS/STING‐mediated immune responses	28
Role of calcium in hormone‐independent and ‐resistant breast cancer	28
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004–2015: A comparative population‐based study	28
From non‐coding RNAs to cancer regulators: The fascinating world of micropeptides	27
DNA methylation signatures of cervical pre‐invasive and invasive disease: An epigenome‐wide association study	27
Blood‐based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy	27
FSCN1 as a new druggable target in adrenocortical carcinoma	27
Let's talk about sex: Survival among females and males in a real‐world cohort treated with pembrolizumab for non‐small cell lung cancer	27
Trends in the incidence of ovarian cancer in sub‐Saharan Africa	26
Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan	26
The effect of diet and nutrition on T cell function in cancer	26
CXCR4 expression is associated with proneural‐to‐mesenchymal transition in glioblastoma	25
Long‐term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project	25
Systemic circulating microRNA landscape in Lynch syndrome	25
Serum IgG N‐glycans enable early detection and early relapse prediction of colorectal cancer	25
Annexin A2: The diversity of pathological effects in tumorigenesis and immune response	25
Female reproductive and hormonal factors and lung cancer mortality among never‐smokers: A prospective cohort study of 287 408 Chinese women	24
Prognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer	24
Long‐term follow‐up of cervical cancer incidence after normal cytological findings	24
ERRATUM	24
Proteomic signature for detection of high‐grade ovarian cancer in germline BRCA mutation carriers	24
Acute aerobic exercise‐conditioned serum reduces colon cancer cell proliferation in vitro through interleukin‐6‐induced regulation of DNA damage	24
Reply to: Comments on “Associations of plasma omega‐6 and omega‐3 fatty acids with overall and 19 site‐specific cancers: A population‐based cohort study in UK Biobank”	23
Peri‐weaning cholera toxin consumption suppresses chemically‐induced carcinogenesis in mice	23
Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database	23
Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy	23
Comments on the paper “Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer” by Y. Chen et al.	23
Long‐term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast	23
Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial	23
Reproductive history and breast cancer survival: Findings from the African breast cancer—Disparities in outcomes cohort and implications of Africa's fertility transition on breast cancer prognosis	23
Absolute quantification of 2‐hydroxyglutarate on tissue by matrix‐assisted laser desorption/ionization mass spectrometry imaging for rapid and precise identification of isocitrate dehydrogenase mutati	23
Fetal growth and pediatric cancer: A pan‐cancer analysis in 7000 cases and 37 000 controls	23
The United States experience with diagnosing and treating esophageal cancer during the SARS‐CoV‐2 pandemic: A retrospective cohort study	23
Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)	23
Cumulative risks of false positive recall and screen‐detected breast cancer after multiple screening examinations	23
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)‐induced phenotypes for platinum sensitivity and long‐term su	22
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts	22
Associations between early‐life and in utero infections and cytomegalovirus‐positive acute lymphoblastic leukemia in children	22
KMT2D links TGF‐β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity	22
Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis	22
Time intervals in the care pathway to cancer diagnosis during the COVID‐19 pandemic: A large retrospective study from a high‐volume center	22
Underdiagnosed cancer during COVID‐19 pandemic and return to normality	22
Combination of PD‐1/PD‐L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma	22
Issue Information	21
	21
Issue Information	21
Reply to: Comments on “Psychosocial factors, health behaviors and risk of cancer incidence: Testing interaction and effect modification in an individual participant data meta‐analysis”	21
After COVID‐19, telemedicine may be used in addition to usual care and not in lieu of: Implications for health systems	21
Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study	21
Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors	20
Pioneering sustainable treatment delivery in childhood leukemia through synchronous telemedicine—A pilot study	20
Neuro–astrocytic network in breast cancer brain metastases: Adaptive mechanisms and novel therapeutic targets	20
Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation	20
Incidence of cancer among Nordic police officers	20
Comparative sequencing study of mismatch repair and homology‐directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan	20
Sex‐ and site‐specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort	20
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure	20
Chronic acidosis rewires cancer cell metabolism through PPARα signaling	20
The importance of ethnicity: Are breast cancer polygenic risk scores ready for women who are not of White European origin?	20
Issue Information	20
Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS	20
Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching	20

Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients	19
Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical tri	19
Correction to “Natural resistance to cancer: A window of hope”	19
Issue Information	19
	19
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)	19
Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all‐cause mortality	19
Issue Information	19
	19
Long‐term exposure to air pollution and liver cancer incidence in six European cohorts	19
Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA‐CC ANRS 1237	19
How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation	19
Issue Information	19
Issue Information	19
Comments on: “Meta‐analysis of agreement/concordance statistics in studies comparing self‐ vs clinician‐collected samples for HPV testing in cervical cancer screening”	18
Antibodies against high‐risk human papillomavirus proteins as markers for noncervical HPV‐related cancers in a Black South African population, according to HIV status	18
Assessment of pain prevalence in cancer patients undergoing anticancer treatments and in cancer survivors after completion of anticancer treatments: A French nationwide cross‐sectional study	18
	18
Association between serum urea concentrations and the risk of colorectal cancer, particularly in individuals with type 2 diabetes: A cohort study	18
High‐risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020	18
Risk of breast cancer in men in relation to weight change: A national case‐control study in England and Wales	18
Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck	18
Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor	18
Association between family history with lung cancer incidence and mortality risk in the Asia Cohort Consortium	18
	18
Issue Information	18
mitoDataclean: A machine learning approach for the accurate identification of cross‐contamination‐derived tumor mitochondrial DNA mutations	18
Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival	18
Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial	18
Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms	18
Erratum	18
Issue Information	18
Endometrial cancer prognosis in women with endometriosis and adenomyosis: A retrospective nationwide cohort study of 40 840 women	18
Phase I clinical trial of HC‐1119: A deuterated form of enzalutamide	17
Pro‐tumoral behavior of omental adipocyte‐derived fibroblasts in tumor microenvironment at the metastatic site of ovarian cancer	17
Inhibition of the Rho/MRTF pathway improves the response of BRAF‐resistant melanoma to PD1/PDL1 blockade	17
Epidemiological and genetic evidence for the relationship between ABO blood group and human cancer	17
Familial aggregation of early‐onset cancers in early‐onset breast cancer families	17
Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV	17
Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis	17
Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population‐based registry data	17
Neoadjuvant docetaxel plus carboplatin vs epirubicin plus cyclophosphamide followed by docetaxel in triple‐negative, early‐stage breast cancer (NeoCART): Results from	17
Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus	17
Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma	17
Special issue “The advance of solid tumor research in China”: Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy	17
Response to: Comments on “Epidemiological trends and survival of oropharyngeal cancer in a high HPV‐prevalent area: A Danish population‐based study from 2000 to 2020”	17
Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study	17
Recent trends in hereditary breast cancer incidence by race and age in KwaZulu‐Natal, South Africa: An 11‐year single‐centre retrospective study (2011‐2021)	17
Efficacy and immunogenicity of AS04‐HPV‐16/18 vaccine in females with existing cervical HR‐HPV infection at first vaccination: A pooled analysis of four large clinical trials wor	17
Assessing the risk of cervical neoplasia in the post‐HPV vaccination era	17
National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population‐based cancer registries	17
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth	17
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer	16
Exosomes: Mediators in microenvironment of colorectal cancer	16
Genetic variants of CHEK1, PRIM2 and CDK6 in the mitotic phase‐related pathway are associated with nonsmall cell lung cancer survival	16
Issue Information	16
Extracellular vesicle long RNA markers of early‐stage lung adenocarcinoma	16
Switching clinic‐based cervical cancer screening programs to human papillomavirus self‐sampling: A cost‐effectiveness analysis of vaccinated and unvaccinated Norwegian women	16
Paid and unpaid productivity losses due to premature mortality from cancer in Europe in 2018	16
RETRACTION: A Multiplicity of Anti‐Invasive Effects of Farnesyl Transferase Inhibitor SCH66336 in Human Head and Neck Cancer	16
Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases	16
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus‐related hepatocellular carcinoma	16
Single‐cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer	16
Triage performance and predictive value of the human gene methylation panel among women positive on self‐collected HPV test: Results from a prospective cohort study	16
PARP mediated DNA damage response, genomic stability and immune responses	15
Lifetime incidence risk for gastric cancer in the Helicobacter pylori‐infected and uninfected population in Japan: A Monte Carlo simulation study	15
Prospective evaluation of quantitative response parameter in patients with Gastrointestinal Stroma Tumor undergoing tyrosine kinase inhibitor therapy—Impact on clinical outcome	15
Trends in epidemiology and primary treatment of anal squamous cell carcinoma in the Netherlands (1990–2021)	15
Comprehensive genomic profiling of salivary gland carcinoma: Analysis of the Center for Cancer Genomics and Advanced Therapeutics database in Japan	15
	15
Issue Information	15
Issue Information	15
Validation of novel DNA methylation markers in cervical precancer and cancer	15
Mechanisms and strategies for safe chimeric antigen receptor T‐cell activity control	15
Removal of gemcitabine‐induced senescent cancer cells by targeting glutaminase1 improves the therapeutic effect in pancreatic ductal adenocarcinoma	15
Experiences with thermal ablation for cervical precancer treatment after self‐collection HPV‐based screening in the ASPIRE Mayuge randomized trial	15
Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non‐metastatic renal cell carcinoma: Systematic review and meta‐analysis	15
Metabolic characterization of sphere‐derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance	15
Search for germline gene variants in colorectal cancer families presenting with multiple primary colorectal cancers	15
Issue Information	15
Effect of a physical activity intervention on lower body bone health in childhood cancer survivors: A randomized controlled trial (SURfit)	15
Amplified Ca2+ dynamics and accelerated cell proliferation in breast cancer tissue during purinergic stimulation	15
Neurosurgical morbidity in pediatric supratentorial midline low‐grade glioma: Results from the German LGG studies	15
Phase III randomized trial comparing palliative systemic therapy to best supportive care in advanced esophageal/GEJ cancer	15
A proteome‐wide analysis unveils a core Epstein–Barr virus antibody signature of classic Hodgkin lymphoma across ethnically diverse populations	15
The current therapeutic cancer vaccines landscape in non‐small cell lung cancer	15
Risk of secondary nonhematologic malignancies after allogeneic stem cell transplantation: A nationwide case‐control cohort study	15
Issue Information	15
Issue Information	15
	15
Targeting type I collagen for cancer treatment	14
Issue Information	14
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab	14
A transcriptome‐wide association study identifies novel candidate susceptibility genes for prostate cancer risk	14
	14